Europe eyes arthritis drug for COVID-19 cases

AMSTERDAM – The European Medicines Agency has started an accelerated review process to determine if a common pain-management drug might help people hospitalized with severe infectious-disease, months after the drug was granted an emergency use authorization in the U.S. In a statement Monday, the EU drug regulator said it was assessing an application to extend…

Read More

FDA greenlights COVID-19 booster vaccine for some immunocompromised patients

The U.S. Food and Drug Administration expanded emergency use of Pfizer-BioNTech and Moderna’s infectious-disease infectious-diseaseto authorize a booster shot for certain immunocompromised patients. HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise about 2.7% of the U.S. adult population.  infectious-disease Growing evidence had suggested select immunocompromised patients mount a diminished protective…

Read More

WHO says COVID-19 origin needs more studies as top expert's lab 'concern' made public for first time

The world-health-organization” target=”_blank”>World Health Organization’s< appears to have contradicted his February statement dismissing the infectious-disease – admitting that it was not “extremely unlikely” as the WHO said at the time, but “probable.” On Thursday, the WHO in a new statement admitted that the lab-leak was not “extremely unlikely” after all. “On review of the phase…

Read More

CDC: Kids’ long COVID often involves fatigue, headache

Children experiencing lingering symptoms weeks to months after initial infectious-disease infection, or so-called long COVID, most often face fatigue and headache, Dr. rochelle-walensky” target=”_blank”>Rochelle Walensky< In a recent statement from Dr. Amanda Morrow and Dr. Laura Malone, co-directors of the Kennedy Krieger Institute’s Post COVID-19 Pediatric Rehabilitation Clinic, long COVID in kids can involve a…

Read More

Walensky: FDA working to OK Pfizer, Moderna COVID booster shots for certain immunocompromised patients

The Food and Drug Administration (FDA) is rapidly approaching a potential authorization for a third dose of Pfizer’s and Moderna’s infectious-disease infectious-disease among certain immunocompromised patients, within the next day, Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC) said Thursday. “Emerging data show that certain people who are immune compromised,…

Read More

American Cancer Society urges COVID-19 booster efforts among immunocompromised patients

Ahead of an anticipated FDA authorization for infectious-disease booster vaccines among certain individuals with weakened immune systems, the American Cancer Society has voiced full support behind efforts to offer cancer patients greater protection against infectious-disease. CLICK HERE TO FIND A COVID-19 VACCINE NEAR YOU HIV and cancer patients, organ transplant recipients and those taking immunosuppressant…

Read More